{"filing":{"accession_number":"0000055529-26-000031","cik":"0000055529","ticker":"KEQU","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","form":"8-K","filing_date":"2026-09-09","report_date":"2026-09-09","primary_document":"kequ-20260909.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/55529/000005552926000031/kequ-20260909.htm"},"events":[{"id":32368,"run_id":29736,"accession_number":"0000055529-26-000031","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Kewaunee Scientific issued a press release on September 9, 2026, announcing financial results for the first quarter of fiscal year 2027 ended July 31, 2026. The disclosure includes detailed quarterly results (sales of $66.3M, net earnings of $1.7M, diluted EPS of $0.58), segment performance, balance sheet metrics, and management commentary. This is a standard quarterly earnings release filed under Item 2.02 with the press release furnished as Exhibit 99.1.","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","ticker":"KEQU","filing_date":"2026-09-09","form":"8-K","submitted_at":null,"items":[{"id":35528,"accession_number":"0000055529-26-000031","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Kewaunee Scientific issued a press release on September 9, 2026, announcing financial results for the first quarter of fiscal year 2027 ended July 31, 2026. The disclosure includes detailed quarterly results (sales of $66.3M, net earnings of $1.7M, diluted EPS of $0.58), segment performance, balance sheet metrics, and management commentary. This is a standard quarterly earnings release filed under Item 2.02 with the press release furnished as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-09T20:27:53.384603+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35528,"accession_number":"0000055529-26-000031","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Kewaunee Scientific issued a press release on September 9, 2026, announcing financial results for the first quarter of fiscal year 2027 ended July 31, 2026. The disclosure includes detailed quarterly results (sales of $66.3M, net earnings of $1.7M, diluted EPS of $0.58), segment performance, balance sheet metrics, and management commentary. This is a standard quarterly earnings release filed under Item 2.02 with the press release furnished as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-09T20:27:53.384603+00:00","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","ticker":"KEQU","filing_date":"2026-09-09"}]}